SynthesisDiabetes/metabolism research and reviews2017

Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index.

Riccardo C Bonadonna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.